Status:
COMPLETED
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
Lead Sponsor:
Dong-A ST Co., Ltd.
Conditions:
Hyperlipidemia
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
Comparison of the efficacy and safety of Cresnon® and Crestor® in patients with hyperlipidemia \- 8-week, active-controlled, open-label, randomized, parallelgroup, fixed-dose, noninferiority, multice...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age ≥ 20
- Persons who have not reached LDL-C targeted level in accordance with the treatment guidelines for dyslipidemia released by Korean Society of Lipidology and Atherosclerosis
Exclusion
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
223 Patients enrolled
Trial Details
Trial ID
NCT02280590
Start Date
September 1 2014
Last Update
July 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea